Kinase suppressor of Ras 1 (KSR1) and KSR2 are scaffolds that promote extracellular signal-regulated kinase (ERK) signaling but have dramatically different physiological functions. KSR2 ؊/؊ mice show marked deficits in energy expenditure that cause obesity. In contrast, KSR1 disruption has inconsequential effects on development but dramatically suppresses tumor formation by activated Ras. We examined the role of KSR2 in the generation and maintenance of the transformed phenotype in KSR1 (28, 55, 57) . In C. elegans, KSR2 is required for Ras-mediated signaling during germ line meiotic progression and functions redundantly with KSR1 during development of the excretory system, hermaphrodite vulva, and male spicules (46). Subsequent studies in mammalian systems showed that KSR1 and KSR2 interact with Raf, MEK, and ERK to coordinate the intensity and duration of ERK signaling (3, 9, 10, 29, 31, 54, 62, 63) . Manipulation of KSR1 in mouse embryo fibroblasts (MEFs) revealed the intricate regulation of ERK signaling to enhance the oncogenic potential of Ras, adipogenic differentiation, and replicative senescence (29-31). Studies with mammalian KSR2 showed that it uniquely coordinates calcium-mediated Rasto-ERK signaling (10). KSR scaffolds have also been implicated in regulating cellular metabolism, as both KSR1 Ϫ/Ϫ and KSR2 Ϫ/Ϫ mice exhibit metabolic defects. KSR1 Ϫ/Ϫ mice have hypertrophic adipocytes (29). Disruption of KSR2 in mice led to reduced expression of genes responsible for oxidative phosphorylation (OXPHOS) and deregulated 5= AMP-activated protein kinase (AMPK)-mediated processes, which led to spontaneous obesity and insulin resistance. KSR2 interacts with all AMPK subunits and promotes AMPK phosphorylation in vitro and in vivo (6). KSR1 mediates the Ras-dependent upregulation of peroxisome proliferator-activated receptor ␥ coactivator 1␣ (PGC1␣) and estrogenrelated receptor ␣ (ERR␣), transcription factors that regulate mitochondrial biogenesis in MEFs, and is essential to promote anchorage-independent growth (12).
T he kinase suppressor of Ras (KSR) proteins are molecular scaffolds that coordinate Raf/MEK/extracellular signal-regulated kinase (ERK) kinase cascade signaling (10, 31, 44) . KSR1 is an essential component for Ras signaling, as loss-of-function alleles restore the hyperactive Ras phenotype in Drosophila melanogaster and Caenorhabditis elegans (28, 55, 57) . In C. elegans, KSR2 is required for Ras-mediated signaling during germ line meiotic progression and functions redundantly with KSR1 during development of the excretory system, hermaphrodite vulva, and male spicules (46) . Subsequent studies in mammalian systems showed that KSR1 and KSR2 interact with Raf, MEK, and ERK to coordinate the intensity and duration of ERK signaling (3, 9, 10, 29, 31, 54, 62, 63) . Manipulation of KSR1 in mouse embryo fibroblasts (MEFs) revealed the intricate regulation of ERK signaling to enhance the oncogenic potential of Ras, adipogenic differentiation, and replicative senescence (29) (30) (31) . Studies with mammalian KSR2 showed that it uniquely coordinates calcium-mediated Rasto-ERK signaling (10) . KSR scaffolds have also been implicated in regulating cellular metabolism, as both KSR1
Ϫ/Ϫ and KSR2
Ϫ/Ϫ mice exhibit metabolic defects. KSR1 Ϫ/Ϫ mice have hypertrophic adipocytes (29) . Disruption of KSR2 in mice led to reduced expression of genes responsible for oxidative phosphorylation (OXPHOS) and deregulated 5= AMP-activated protein kinase (AMPK)-mediated processes, which led to spontaneous obesity and insulin resistance. KSR2 interacts with all AMPK subunits and promotes AMPK phosphorylation in vitro and in vivo (6) . KSR1 mediates the Ras-dependent upregulation of peroxisome proliferator-activated receptor ␥ coactivator 1␣ (PGC1␣) and estrogenrelated receptor ␣ (ERR␣), transcription factors that regulate mitochondrial biogenesis in MEFs, and is essential to promote anchorage-independent growth (12) .
AMPK is a trimeric enzyme regulating the cell energy homeostasis that is activated during nutrient deprivation due to increased intracellular AMP/ATP ratios, as the allosteric activator AMP promotes AMPK activity during energy stress (16, 51) . AMP and ADP promote the binding of ␣ and ␥ subunits to protect dephosphorylation of Thr172 in the ␣ subunit (45, 61) . As ATP levels increase, AMPK activity is suppressed (45, 51) . Activation of AMPK promotes the activation of catabolic pathways that generate ATP and the inhibition of anabolic pathways that consume ATP. AMPK activation promotes glucose and fatty acid uptake, glycolysis, and fatty acid oxidation and enhances mitochondrial biogenesis while inhibiting fatty acid synthesis, gluconeogenesis, glycogen storage, and cholesterol biosynthesis (53) .
KSR1 is the most extensively characterized of the KSR scaffolds involved in the regulation of cell proliferation and tumorigenesis.
T cells isolated from KSR1
Ϫ/Ϫ mice exhibited lower proliferative rates (44) . Elevating KSR1 protein to levels that optimize ERK activity enhanced the proliferative rate of MEFs (31) . In vitro and in vivo studies have demonstrated that KSR1 is required for Rasinduced transformation. The deletion of KSR1 in MEFs abolished the ability of H-Ras V12 to promote anchorage-independent growth due to decreased ERK activation (31, 44) . KSR1 Ϫ/Ϫ mice are resistant to tumor formation in mammary epithelial cells expressing polyomavirus middle T or Ras-induced skin tumorigenesis (35, 44) . We tested the role of KSR2 in cell proliferation and anchorage-independent growth to determine the extent to which KSR2 contributes to the transformed phenotype. Our data show that KSR2 expression enhances the proliferative rate of MEFs and KSR2 depletion reduces tumor cell growth. KSR2 expression in MEFs promotes anchorage-independent growth and synergizes were isolated by centrifugation at 11,000 to 15,000 ϫ g for 10 min. Protein concentrations were quantified using the bicinchoninic acid (BCA) protein assay (Promega). Proteins were resolved using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose membranes (Li-COR). Membranes were blocked in Odyssey blocking buffer (Li-COR) for 1 to 12 h and probed with primary antibodies (1 to 16 h) and secondary antibodies (45 min) in a 1:1 mixture of Odyssey blocking buffer and Tris-buffered saline with 0.1% Tween 20 and hybridized proteins detected using the Odyssey imaging system (Li-COR). All reagents were obtained from Sigma, unless specified.
Immunoprecipitations. To detect KSR2-ERK association, transfected 293T cells were subjected to serum starvation for 4 h and stimulated with human epidermal growth factor (EGF) (Life Technologies) for 5 min. Cells were lysed in lysis buffer containing 25 mM Tris (pH 7.4), 125 mM NaCl, 1 mM MgCl 2 , and 1% Brij 98 with 10 g/ml aprotinin, 20 mM leupeptin, 0.5 mM sodium orthovanadate, 2 mM EDTA, 10 mM sodium fluoride, 2 mM EGTA, 10 mM ␤-glycerophosphate, and 1 mM PMSF. Lysates were cleared and protein concentrations determined. To detect KSR2-MEK association, transfected cycling 293T cells were lysed in Igepal lysis buffer as described above. Total protein (2 mg) was immunoprecipitated overnight with 40 l of a 1:1 slurry of anti-FLAG-conjugated agarose in phosphate-buffered saline (PBS). The beads were washed three times in lysis buffer, and protein was eluted using the FLAG peptide. To detect KSR proteins in tumor cells, where indicated, total protein (1 mg) was incubated with 4 g of KSR1 or KSR2 antibodies overnight, subjected to a 1:1 slurry of protein G-PBS for 30 min, washed three times with lysis buffer, and boiled in sample buffer. The collected supernatants were analyzed via Western blotting. All reagents were obtained from Sigma, unless otherwise specified.
Reagents. The following primary antibodies were purchased from Cell Signaling, unless otherwise indicated: FLAG (M2; Sigma), KSR2 (rabbit polyclonal raised against a recombinant protein containing amino acids 168 to 262 of mouse KSR2 [for the detection of ectopic proteins]), KSR2 (1G4 [lot 08344-1G4]; Abnova), KSR2 (K75; Santa Cruz), ␣-tubulin (B-5-1-2; Santa Cruz), c-H-Ras (Ab-1; EMD Biosciences), phospho-Thr202/ Tyr204 ERK1/2 (9106), ERK1/2 (9102), ERK1 (sc-93; Santa Cruz), KSR1 (H-70; Santa Cruz), KSR1 (C-19; Santa Cruz), Myc (4A6; Thermo Scientific), phospho-Thr172 AMPK␣ (2531), AMPK␣ (2532), AMPK␣1 (2795), AMPK␣2 (R&D Systems), AMPK␥1 (4187), phospho-Ser79 acetyl coenzyme A (CoA) carboxylase (ACC) (3661), ACC (3676), phospho-Ser792 Raptor (2083), and Raptor (2280). Anti-mouse and anti-rabbit antibodies conjugated with Infrared Dye 680LT (Li-COR), Alexa Fluor 680 (Life Technologies), or Infrared Dye 800CW (Rockland or Li-COR) were used to detect primary antibodies. 5-Aminoimidazole-4-carboxamide 1-␤-Dribofuranoside (AICAR) was purchased from Toronto Research Chemicals. U0126 was purchased from Cell Signaling. ON-TARGETplus siRNA preparations targeting AMPK␣1, AMPK␣2, and AMPK␥1 were obtained from Thermo Scientific. Constitutively active AMPK␣2 (AMPK␣2⌬312) and kinase dead/dominant-negative AMPK␣2 (AMPK␣2-K45R) constructs of rat origin were gifts from Morris Birnbaum (University of Pennsylvania). Mutation of amino acid 172 from Thr to Asp was carried out via site-directed mutagenesis [AMPK␣2⌬312(T172D)] (52).
In situ ERK activation assay. The in situ ERK activation assay was performed as previously described (30, 31) . Briefly, MEFs were seeded at 5 ϫ 10 3 cells per well in a 96-well black-wall plate, in triplicate, 16 h prior to analysis and subjected to an in situ plate assay using a Li-COR Odyssey infrared imaging system to quantify ERK activation. Cells at 80% confluence were subjected to serum starvation for 4 h and treated with 25 ng/ml platelet-derived growth factor (PDGF) in DMEM-1% bovine serum albumin at the indicated time points. Primary antibodies and secondary antibodies were used to detect phosphorylated and total ERK, respectively. The microplates were imaged and measurements acquired using a Li-COR Odyssey imaging system. Cell proliferation assays. Cells (4 ϫ 10 4 MEF, 2.5 ϫ 10 4 MIN6, or 5 ϫ 10 3 NG108-15) were seeded in 35-mm-diameter dishes. In triplicate, cells were treated with trypsin at the indicated time points, collected, and counted using a Beckman Coulter counter. To account for discrepancies in plating, the first count was performed 4 h after plating. Anchorage-independent growth assays. A total of 5 ϫ 10 3 cells were suspended in Iscove's modified Dulbecco's medium (IMDM) (Life Technologies) supplemented with 15% FBS, 2 mM L-glutamine, 1% Pen/Strep, 2 g/ml puromycin, and 0.65% NuSeive GTG agarose (Thermo Scientific) and seeded on a layer of IMDM supplemented with 0.32% NuSeive GTG agarose in 35-mm-diameter dishes. MIN6 cells were supplemented with an additional mixture of 2 mM L-glutamine, 1 mM sodium pyruvate, 10 mM HEPES, and 50 M ␤-mercaptoethanol. NG108-15 cells were supplemented with HAT solution. Colonies were counted, and representative photomicrographs were taken at the indicated times. For shortterm anchorage-independent growth assays, 96-well microplates were coated with poly(2-hydroxyethyl methacrylate) [poly(HEMA)] (Sigma) to prevent cell attachment. A total of 5 ϫ 10 3 cells were seeded in full media, and the viability of cells was assessed using CellTiter-Glo reagent (Thermo Scientific) at the indicated time points.
Metabolic assays. The rate of nutrient consumption and the maximal capacity for OXPHOS and aerobic glycolysis were determined by measuring the oxygen consumption rate (OCR) or extracellular acidification rate (ECAR) using an XF24 Analyzer (Seahorse Biosciences). To determine glucose metabolism levels, 4 ϫ 10 4 MIN6 cells were seeded in a 24-well XF microplate in bicarbonate-free low-buffer DMEM containing 2.5 mM glucose. OCR measurements were performed prior to and after an injection of DMEM or 22.5 mM glucose. Similarly, glutamine consumption was assessed in 4 ϫ 10 4 MIN6 and 2 ϫ 10 4 NG108-15 cells after they were seeded in bicarbonate-free low-buffer DMEM. OCR measurements were performed prior to and after a 10 mM L-glutamine ( 
RESULTS
KSR2 is a scaffold for the ERK signaling pathway and regulates cell proliferation. KSR1 is required for maximal activation of ERK and facilitates signaling by growth factors and oncogenic Ras by spatially and temporally regulating ERK signaling to affect cell fate (29) (30) (31) . The KSR1 paralog, KSR2, modulates calcium-induced processes by mediating Ras with respect to ERK signaling (10) . Extensive studies of the role of KSR1 in cell proliferation and oncogenic potential have been performed, but little is known about the regulation of these cell fates by KSR2. Previous work in our laboratory used KSR1 Ϫ/Ϫ MEFs to characterize KSR1 function (12, (29) (30) (31) . MEFs do not express KSR2 mRNA or protein, making KSR1 Ϫ/Ϫ MEFs effectively doubly null for KSR1 and KSR2 (29) . To assess distinct and overlapping functions of the KSR scaffolds, KSR2 was ectopically expressed in KSR1 Ϫ/Ϫ MEFs. The levels of KSR2 expression were modulated using a bicistronic vector encoding FLAG-tagged KSR2 and green fluorescent protein (GFP). MEFs expressing GFP were separated via flow cytometry into two populations. One population expressed the lowest detectable level of GFP. A second population expressed high levels of GFP. The level of KSR2 expression relative to that of GFP was then confirmed via Western blotting (Fig. 1A) . For comparison, FLAG-tagged KSR1 was reintroduced to KSR1 Ϫ/Ϫ MEFs at a level that significantly enhanced growth factor-induced ERK phosphorylation above wild-type levels (31) . To characterize the role of KSR2 in growth factor-mediated ERK activation, each population was stimulated with PDGF and the level of ERK phosphorylation was assessed over a 30-min time course. In comparison to KSR1 Ϫ/Ϫ MEFs expressing GFP only, KSR1 Ϫ/Ϫ MEFs expressing low levels of KSR2 restored growth factor-induced ERK activation to an intensity similar to that seen with ectopic KSR1 (Fig. 1C) . However, the level of ectopic KSR2 that restored ERK phosphorylation was one-ninth the level of KSR1 that induced a similar effect (Fig. 1B) . A level of KSR2 approximately three times higher than that of ectopic KSR1 (Fig. 1B) impaired ERK phosphorylation at a level below that observed in KSR1 Ϫ/Ϫ MEFs expressing GFP alone (Fig. 1C) . Strikingly, intermediate levels of KSR2 expression inhibited growth factor-induced ERK activation in a concentration-dependent manner (data not shown). These data indicate that KSR2 rescues ERK activation debilitated by the disruption of KSR1 but also that KSR1 Ϫ/Ϫ MEFs are more sensitive to KSR2 than KSR1.
Moderately increasing the levels of KSR1 enhanced the growth rate of KSR1 Ϫ/Ϫ MEFs. However, this phenotype was restored when KSR1 levels were elevated to levels 21-fold above those found in wild-type MEFs. Since the effects on cell proliferation by KSR1 paralleled the biological effects on ERK activation, it was postulated that KSR1 mediates cell proliferation through regulation of ERK activity (31) . To assess the role of KSR2 in cell proliferation and determine if it is dependent on ERK activity, the growth rate of KSR1 Ϫ/Ϫ MEFs expressing low or high levels of KSR2 was compared to those of GFP-only cells and cells expressing KSR1. Levels of KSR1 that enhanced ERK activation also accelerated MEF proliferation. KSR2 at low levels that restored ERK activity (Fig. 1C ) also enhanced cell proliferation, albeit not as efficiently as KSR1 (Fig. 1D) . Surprisingly, high levels of KSR2 further increased proliferation of KSR1 Ϫ/Ϫ MEFs beyond that seen with low KSR2 levels, mirroring the growth rate of KSR1 Ϫ/Ϫ MEFs expressing ectopic KSR1. This was an unexpected result, since the high level of KSR2 expression did not mediate ERK activation ( Fig. 1C and D) . These data show that KSR1 and KSR2 regulate cell proliferation; however, they suggest that KSR2 asserts its effect on cell proliferation through a mechanism independent of the Raf/MEK/ERK kinase cascade.
KSR2 regulates cell proliferation independently of ERK signaling. The interaction between ERK and some of its effectors is mediated via a DEF domain, an FXFP motif, located on KSR homologs (20) . Mutating this domain on KSR1 incapacitates KSR1-mediated ERK phosphorylation by MEK (30, 38) . To further examine the ability of KSR2 to regulate cell proliferation and its dependence on the Raf/MEK/ERK pathway, the DEF domain of KSR2 was mutated (570 FIFP/AAAP 573) to abolish the KSR2-ERK interaction ( Fig. 2A) . The KSR2.AAAP mutant was transduced into KSR1 Ϫ/Ϫ MEFs using the bicistronic vector described previously. KSR1
Ϫ/Ϫ MEFs expressing either low or high levels of KSR2.AAAP were isolated using the same gates used for wild-type KSR2, and the level of expression was verified by Western blot analysis (Fig. 2B) . The KSR2.AAAP mutant was then examined for its ability to mediate ERK activation in response to growth factors and promote cell proliferation. After assessing ERK activity in situ after PDGF stimulation, abolishing the KSR2-ERK interaction decreased the level of ERK activity mediated by KSR2 expressed at low levels in KSR1 Ϫ/Ϫ MEFs (Fig. 2C) . Furthermore, the level of ERK activity was suppressed in comparison to the level seen with GFP-only infected cells. Expressing KSR2.AAAP at high levels suppressed ERK activity in a manner similar to that seen with expression at low levels, but the effect was not as severe as that seen with expression at high levels of wild-type KSR2 (Fig. 1C and 2C ). As expected, the KSR2-ERK interaction is necessary for KSR2 to mediate growth factor-induced ERK activation.
To determine if the KSR2.AAAP mutant had the ability to enhance cell proliferation, the growth rate of KSR1 Ϫ/Ϫ MEFs expressing low or high levels of KSR2.AAAP was determined and compared to that of cells expressing wild-type KSR2 or GFP-only cells. The results show that, expressed at low levels, KSR2.AAAP increases cell proliferation with a greater effect than wild-type KSR2 (Fig. 1D and 2D) . Furthermore, increasing KSR2.AAAP expression modestly elevated cell proliferation in KSR1 Ϫ/Ϫ MEFs (Fig. 2D) . These data show that the KSR2-ERK interaction is necessary for growth factor-mediated ERK activation but is dispensable for cell proliferation.
Studies with KSR2.AAAP further demonstrated the inverse correlation between cell proliferation and ERK activity mediated by KSR2. Levels of KSR2 that are able to promote ERK activation do not optimally enhance cell proliferation, and levels of KSR2 that are able to optimally enhance cell proliferation do not promote ERK activation ( Fig. 1 and 2A to D) . To further examine this correlation, we sought a KSR2 mutant that hyperstimulates ERK activation by growth factors and tested its ability to enhance cell proliferation. Mutating Cys809 to Tyr on KSR1 leads to hyperstimulation of Raf/MEK/ERK by growth factors (30) and disrupts the KSR1-MEK interaction (30, 38, 54) . As with the KSR1 mutation, the equivalent mutation on KSR2 (KSR2.C907Y) disrupts the KSR2-MEK interaction (Fig. 2E) . KSR1
Ϫ/Ϫ MEFs expressing low and high levels of KSR2.C907Y were isolated via fluorescenceactivated cell sorting (FACS), and the ability of KSR2.C907Y to mediate growth factor-induced ERK activation and cell proliferation was tested. In similarity to the KSR1 results (30) , abolishing the KSR2-MEK interaction did not disrupt the ability of KSR2 to mediate growth factor-induced ERK activation (Fig. 2G) . Moreover, both low and high levels of KSR2.C907Y were capable of mediating ERK activation, indicating that, like that of KSR1, interaction of KSR2 with MEK is not required for ERK activation. However, irrespective of the expression level, KSR2.C907Y did not enhance cell proliferation of KSR1 Ϫ/Ϫ MEFs (Fig. 2H) to the rates observed in MEFs expressing high levels of wild-type KSR2 or KSR2.AAAP. Together, these data demonstrate that the proliferative effects of KSR2 are independent of the Raf/MEK/ERK kinase cascade.
KSR2-mediated anchorage-independent growth is not dependent on ERK signaling. KSR1 is required for oncogenic Rasmediated cell transformation and tumorigenesis, a biological action attributed to its role as a scaffold regulating ERK signaling (31, 35, 44) . Furthermore, activated Ras requires KSR1 to promote anchorage-independent growth in KSR1 Ϫ/Ϫ MEFs (31). To assess the role of KSR2 in oncogenic Ras-mediated anchorageindependent growth, H-Ras V12 or the control vector was introduced in KSR1 Ϫ/Ϫ MEFs simultaneously with KSR2. Low and high levels of KSR2 expression were isolated, and the expression levels of KSR2 and H-Ras V12 were confirmed via Western blot analysis (Fig. 3A) . The ability of these cells to promote anchorageindependent growth in soft agar was determined. Expressing KSR2 at low levels did not significantly enhance the ability of H-Ras V12 to form colonies in soft agar compared to the results seen with cells expressing GFP only. However, expressing high levels of KSR2 did enhance H-Ras V12 -induced anchorage-independent growth in KSR1 Ϫ/Ϫ MEFs. Interestingly, in the absence of H-Ras V12 , KSR2 promoted colony formation in a dose-dependent manner in KSR1 Ϫ/Ϫ MEFs (Fig. 3B ). Since only low levels of KSR2 expression mediate PDGF-induced ERK activation, these data suggest that ERK signaling is not required for the effects of KSR2 on anchorage-independent growth in the presence or absence of H-Ras V12 . To further examine this possibility, KSR1
Ϫ/Ϫ MEFs expressing low or high levels of the KSR2.AAAP mutant with or without H-Ras V12 were isolated (Fig. 3A) and tested for their ability to grow in soft agar. KSR2.AAAP was equal to wild-type KSR2 in its ability to promote anchorage-independent growth in the presence or absence of H-Ras V12 . Only high levels of KSR2.AAAP expression were capable of enhancing H-Ras V12 -mediated anchorageindependent growth. However, KSR2.AAAP alone was able to promote anchorage-independent growth to levels similar to those seen with H-Ras V12 alone (Fig. 3B ). These data suggest that KSR2 does not directly mediate but acts synergistically with H-Ras V12 to promote H-Ras V12 -mediated anchorage-independent growth. Moreover, the effect of KSR2 on anchorage-independent growth is not dependent on ERK signaling and is conceivably mediated through an alternative signaling pathway.
KSR2 knockdown affects tumor cell proliferation but not growth factor-mediated ERK activation. The tumor cell lines MIN6 and NG108-15 express KSR2 at levels detectable by Western blot analysis. KSR2 depletion by RNA interference (RNAi) was used on each line to test its effect on growth factor-mediated ERK activation and cell proliferation. Knockdown of KSR2 decreased proliferation of both MIN6 and NG108-15 cells (Fig. 4A and B) , affirming the importance of KSR2 in regulating cell proliferation. To determine if KSR2 depletion had any effect on growth factormediated ERK activation, MIN6 and NG108-15 were treated with epidermal growth factor (EGF) over a time course of 30 min and the levels of phosphorylated ERK analyzed via Western blot analysis. KSR2 depletion modestly decreased EGF-mediated ERK activation in both MIN6 and NG108-15 cells (Fig. 4C and D) .
Since MIN6 and NG108-15 cells express both KSR1 and KSR2, it is possible that KSR2 depletion only modestly decreased EGFmediated ERK activation due to the ability of KSR1 to compensate for the absence of KSR2. To examine this possibility, KSR1 was depleted in these cell lines. Similarly to that of KSR2, knockdown of KSR1 decreased proliferation of MIN6 and NG108-15 cells (Fig. 4E and F) . Depletion of KSR1 completely abrogated EGFstimulated ERK activation in each tumor cell line ( Fig. 4G and   4H ), indicating that KSR2 alone cannot compensate for the absence of KSR1 and is not sufficient to mediate the EGF response in MIN6 and NG108-15 cells. These data complement the results obtained with MEFs and reinforce the idea that the ability of KSR2 to regulate cell proliferation is mediated primarily through signaling pathways other than the Raf/MEK/ERK kinase cascade.
KSR2 is required for proper activation of AMPK in tumor cells. KSR2 associates with AMPK subunits ␣, ␤, and ␥ (6, 10). In vivo studies showed that KSR2 deletion led to obesity, insulin resistance, and disruption of AMPK-mediated effects on metabolism. The presence of KSR2 was required for AMPK activation in vivo and in vitro (6) . To determine if the depletion of KSR2 affects the activation of AMPK, phosphorylation of Thr172 on AMPK␣ was assessed in MIN6 cells stimulated with the AMPK agonist AICAR (5) after KSR2 RNAi. Depletion of KSR2 led to a 50% reduction in the levels of phosphorylation on Thr172, which is critical to sustain catalytic activity of the AMPK␣ subunit (Fig. 5A) . To determine if the activity of AMPK directed toward its substrates also required KSR2, phosphorylation on Ser79 of ACC and Ser792 of Raptor was examined. Coincident with decreased phosphorylation of Thr172 on AMPK␣, phosphorylation decreased on ACC and Raptor by approximately 50% and 25%, respectively (Fig. 5A) . Moreover, depletion of KSR2 led to a reduction in the basal levels of AMPK␣ and ACC. These results reinforce those observed previously for NG108-15 cells (6) and raise the possibility that AMPK may mediate the effects of KSR2 on cell transformation.
To determine if ERK activity is required for AICAR-mediated AMPK activation, MIN6 cells were treated with the MEK inhibitor U0126 prior to stimulation of cells with AICAR. Inhibition of ERK activity did not affect the levels of AMPK␣ phosphorylation on Thr172 due to AICAR treatment. This indicates that the effects of KSR2 on AICAR-mediated AMPK activation are independent of its scaffolding function for the Raf/MEK/ERK pathway (Fig. 5B) .
KSR2 knockdown reduces the rate of nutrient consumption in tumor cells. Tumor cells alter key metabolic pathways, such as glycolysis and glutaminolysis, to meet the bioenergetic and biosynthetic demands necessary to maintain their rapid cell growth and survival (8, 17, 34) . These pathways are regulated by the cellular energy sensor AMPK, which becomes activated when the levels of ATP are low or the AMP/ATP ratio increases (16, 51) . AMPK activation leads to the breakdown of nutrients, such as glucose and fatty acids, to produce ATP (53). Since KSR2 knockdown reduces cell growth and AMPK activation in tumor cells, we postulated that KSR2-depleted cells have lost the ability to properly sense their energy status, impairing nutrient metabolism. Nutrient consumption was analyzed using the Seahorse XF24 Analyzer to measure OCR and ECAR, indices for OXPHOS and aerobic glycolysis, respectively. We showed previously that depletion of KSR2 reduced aerobic glycolysis in NG108-15 cells (6) . Analysis of MIN6 cells shows that KSR2 knockdown led to the reduced ability of these cells to metabolize glucose, as OCR was suppressed (Fig. 6A) . However, in contrast to NG108-15 cell results, pyruvate was diverted to mitochondria in MIN6 cells, as changes in ECAR were not detectable in control and KSR2 knockdown cells (data not shown).
In addition to glucose, tumor cells use fatty acids and glutamine as additional energy sources for the production of ATP (24, 34, 59) . The rate of palmitate consumption was analyzed in MIN6 cells, and the rate of glutamine consumption was examined in MIN6 and NG108-15 cells. KSR2 knockdown inhibited palmitate oxidation in MIN6 cells (Fig. 6B ) and glutamine oxidation in both MIN6 and NG108-15 cells (Fig. 6C and D) . These data reveal KSR2 as a regulator of oxidative metabolism in tumor cells.
AMPK regulates glycolysis and fatty acid oxidation via phosphorylation of phosphofructokinase 2 (PFK-2) and ACC, respectively (7, 36, 37, 39) . KSR2 is necessary for proper AMPK activation (Fig. 5A) . A constitutively active form of AMPK (AMPK-CA) (52) was introduced into KSR2-depleted cells to determine if the role of KSR2 in regulating nutrient consumption is dependent on AMPK activity. Expression of AMPK-CA restored the phosphorylation of ACC and Raptor in the absence of KSR2 (Fig. 5A, lane  5) . Furthermore, AMPK-CA restored the ability of MIN6 cells to properly metabolize glucose (Fig. 6A) and palmitate (Fig. 6B) . Glutamine starvation has been reported to activate AMPK in KRas-transformed fibroblasts and brain tumor cells (14, 42) . The ability of AMPK-CA to restore glutaminolysis in both MIN6 and NG108-15 cells was also examined. Although AMPK has not been shown to directly regulate glutamine oxidation, AMPK-CA restored the ability of MIN6 cells (Fig. 6C ) and NG108-15 cells (Fig.  6D ) to metabolize glutamine in the absence of KSR2. These data demonstrate that KSR2 regulates key metabolic pathways by promoting the proper activation of AMPK.
KSR2 mediates maximal capacity for OXPHOS and aerobic glycolysis in an AMPK-dependent manner. Tumor cells commonly display the ability to shift bioenergetic demand toward aerobic glycolysis. This shift converts the majority of pyruvate to lactate producing NAD ϩ and provides a carbon source for the increased synthesis of macromolecules. Although tumor cells obtain most of their ATP from glycolysis, the tricarboxylic acid (TCA) cycle and OXPHOS remain important processes for the production of key intermediates required for biosynthetic pathways (24, 58) . KSR2 Ϫ/Ϫ mice exhibit lower expression levels of genes that coordinate OXPHOS, including the transcription fac- tor PGC-1␣ (6). KSR1 is required for Ras V12 -mediated upregulation of PGC-1␣ and ERR␣, which maximizes glycolytic and OXPHOS capacity in MEFs (12) . AMPK has been implicated in the regulation of mitochondrial biogenesis and OXPHOS by inducing PGC-1␣ transcriptional activity (21, 56, 64) . To further elucidate the role of KSR2 and AMPK in tumor growth and survival, basal and maximal rates of OXPHOS and glycolysis with and without KSR2 and AMPK-CA were determined. Cells were plated in nutrient-rich media, and the OCR and ECAR were assessed before and after stimulation with FCCP, which uncouples the electron transport chain and reveals maximal OXPHOS and glycolytic potential (1, 4, 11, 60) . To assess the overall maximal capacity of OXPHOS and aerobic glycolysis, cells were treated with successive doses of FCCP adjusted to a final concentration that maximizes OXPHOS. Knockdown of KSR2 decreased both the basal levels and maximal rates of OCR in both the MIN6 (Fig. 7A ) and NG108-15 ( Fig. 7B) cell lines. Expression of AMPK-CA after either cell line was depleted of KSR2 restored basal and maximal OXPHOS to levels observed in control cells (Fig. 7A and B) . Furthermore, KSR2 knockdown reduced the maximal glycolytic capacity of NG108-15 cells but did not affect basal glycolysis, as measured by ECAR. Maximal glycolytic capacity was restored to NG108-15 cells by the expression of AMPK-CA in the absence of KSR2 (Fig. 7C) . ECAR was undetectable prior to and after FCCP treatment in MIN6 cells (data not shown), indicating that these cells need to optimize OXPHOS in order to maintain their tumorigenic properties. These data demonstrate that KSR2 influences maximal glycolytic and OXPHOS potential by regulating the activation of AMPK and emphasize the importance to tumor cells of properly maintaining bioenergetic and biosynthetic demand for sustained cell proliferation.
KSR2 mediates anchorage-independent growth via regulation of AMPK. High levels of KSR2 expression promote ERKindependent anchorage-independent growth in MEFs (Fig. 3B) . hairpin, the KSR2-specific short hairpin, or the KSR2-specific short hairpin and the constitutively active AMPK␣2 (AMPK␣-CA) were seeded in serum-free media for 4 h prior to stimulation with AICAR for 30 min (*, nonspecific bands). (B) MIN6 cells were subjected to serum starvation for 4 h and treated with the MEK inhibitor U0126 for 30 min prior to treatment with AICAR for 30 min at the indicated concentrations. For both panels, KSR2 knockdown, AMPK␣, ACC, Raptor, and ERK activity were examined by immunoblotting (IB) with the indicated antibodies. Immunoblots were quantified using the Li-COR Odyssey system, and the optical densities are illustrated as means Ϯ standard deviations. *, P Յ 0.05; **, P Յ 0.01 (two-tailed Student's t test). Data are representative of the results of at least three independent experiments. KSR2 knockdown reduces the growth rate and AMPK-mediated cell metabolism of MIN6 and NG108-15 cells without affecting growth factor-mediated ERK activation (Fig. 4 to 7) . These data suggest that the AMPK signaling pathway may regulate the effects of KSR2 on anchorage-independent growth. However, AMPK can have opposing roles in cancer. On the one hand, AMPK has been implicated as a tumor suppressor, as its activation leads to cell cycle arrest through negative regulation of the mTOR signaling pathway and activation of p53 (15, 18, 19, 23) . On the other hand, AMPK activity has been shown to have protumorigenic effects. AMPK␣1 and AMPK␣2 or AMPK␤1 depletion decreased cell proliferation and survival of human prostate cancer cells (47, 50) . AMPK also increased the ability of Ras-transformed MEFs and estrogen receptor ␣ (ER␣)-negative tumors to grow as xenografts (33, 48) . Furthermore, AMPK activity is required for the survival of AKT-transformed cells to promote the activation of fatty acid oxidation during glucose deprivation and for the survival of simian virus 40 small T (SV40 ST) antigen-positive tumor cells to maintain energy homeostasis under low-oxygen and hypoxic conditions (2, 32) . A recent study demonstrated that AMPK-regulated NAPDH homeostasis during energy stress is critical to anchorage-independent growth (22) .
To assess whether AMPK activity is necessary for KSR2-mediated anchorage-independent growth, AMPK-CA was expressed in MIN6 and NG108-15 cells depleted of KSR2 and the cells were assayed for their ability to grow in an anchorage-independent manner by the use of two distinct methods. Growth on poly-(HEMA)-coated plates was used for a quick and quantitative measurement of anchorage-independent viability (13) in addition to the standard, long-term assay, soft-agar colony formation. As expected, KSR2 knockdown reduced the ability of MIN6 (Fig. 8A ) and NG108-15 ( Fig. 8B ) cells to grow in an anchorage-independent manner, whereas the growth phenotype was rescued by expression of AMPK-CA. To further assess the importance of AMPK activity for anchorage-independent growth, a dominant-negative form of AMPK (AMPK-KD) (41) was expressed in MIN6 and NG108-15 cells expressing the nontargeting short hairpin. The importance of AMPK activity to cell transformation was demon- strated by the ability of AMPK-KD to impede anchorage-independent viability in a manner similar to that seen with KSR2 depletion (Fig. 8A and B) . Complementing the results observed with the poly(HEMA) assay, KSR2 knockdown suppressed the ability of MIN6 (Fig. 8C ) and NG108-15 ( Fig. 8D ) cells to form colonies in soft agar. AMPK-CA restored the ability of KSR2-depleted cells to form colonies in soft agar, and colonies were similar in size to those observed in control cells. Expression of AMPK-KD in MIN6 cells (Fig. 8C ) and NG108-15 cells (Fig. 8D ) diminished the ability of the cells to form colonies in soft agar. These data indicate that KSR2 mediates anchorage-independent growth through AMPK regulation.
To further demonstrate the importance of AMPK signaling for anchorage-independent growth, MIN6 cells ( Fig. 9A and C) and NG108-15 cells (Fig. 9B and D) were transfected with siRNA targeting the AMPK␥1 subunit alone or the AMPK␣1 and AMPK␣2 subunits in combination. Depletion of AMPK␥1 attenuated anchorage-independent growth in MIN6 (Fig. 9A ) and NG108-15 (Fig. 9B) cells. Interestingly, AMPK␥1 appears necessary to stabilize expression of the ␣ subunit, as a reduction in the expression levels of AMPK␣1 and AMPK␣2 was observed upon AMPK␥1 knockdown ( Fig. 9C and D) . Similar effects on anchorage-independent growth were observed due to simultaneous knockdown of the AMPK␣1 and AMPK␣2 catalytic subunits. These data indicate that AMPK signaling is necessary to mediate anchorageindependent viability and that KSR2 mediates anchorage-independent viability by promoting the activation of AMPK to supply the energy necessary for cells to sustain their tumorigenic potential.
DISCUSSION
Studies in C. elegans have demonstrated that KSR1 and KSR2 have distinct but overlapping developmental effects (46) . Recent work has shown that KSR2, like KSR1, can function as a scaffold to promote ERK signaling (10) . However, the phenotypes of KSR1 and KSR2 disruption in mammals are decidedly distinct. While KSR1 Ϫ/Ϫ mice have subtle defects in hair follicle development and metabolism, they are fertile and otherwise normal and yet markedly resistant to Ras-driven tumor formation (27, 29, 35, 44) . In contrast, KSR2
Ϫ/Ϫ mice are infertile, obese, and insulin resistant and demonstrate defects in AMPK signaling (6) . The current study assessed the role of KSR2 in cell proliferation and transformation. The data show that, independently of its role in ERK scaffold function and ERK signaling, KSR2 alone can induce anchorage-independent growth and also synergize with Ras V12 to enhance transformation in MEFs. KSR2 also facilitates the activation of AMPK, which is essential to nutrient metabolism and the maximal glycolytic and OXPHOS capacity of tumor cells.
The use of KSR1 Ϫ/Ϫ MEFs, which do not express KSR2 (29), revealed overlapping and distinct functions of KSR1 and KSR2. MEFs are exquisitely sensitive to the presence of KSR2. Nine times more KSR1 than KSR2 is required to mediate comparable growth factor-induced ERK activation. Expressing KSR2 at levels similar to those of KSR1 inhibits ERK activation. These data suggest that KSR2 may be more potent than KSR1 in promulgating transmission of signals from Raf to MEK and from MEK to ERK. Recent dissection of KSR1 regulation suggests possible explanations for the increased sensitivity of KSR2 in ERK activation. First, compared to KSR1, KSR2 may be more readily or efficiently poised to translocate to the plasma membrane and assemble the kinase cascade in response to growth factor stimulation (10, 38, 43, 49) . Second, ERK-dependent feedback loops that negatively regulate KSR1-scaffolded complexes may not be as effective in complexes scaffolded by KSR2 (38) . Third, KSR2 may be more efficient than KSR1 in its ability to process MEK-dependent ERK phosphorylation.
Previous data showed a direct, dose-dependent correlation between KSR1 expression, ERK activity, cell proliferation, and FIG 7 KSR2 knockdown affects the maximal metabolic capacity of tumor cells. Cells expressing the nontargeting short hairpin, the KSR2-specific short hairpin, or the KSR2-specific short hairpin and constitutively active AMPK␣2 (AMPK␣-CA) were seeded in growth media on XF24 microplates 16 h prior to analysis. MIN6 (A) and NG108-15 (B and C) cells were plated in bicarbonatefree low-buffered media with a full complement of nutrients as described in Materials and Methods. The rates of oxygen consumption (OCR) and extracellular acidification (ECAR) were measured prior to and 15 min after three successive stimulations with FCCP at the indicated concentrations. Data represent means Ϯ standard errors of the means of the results determined for 3 or 4 wells. *, P Յ 0.05; **, P Յ 0.01; ***, P Յ 0.001 (two-tailed Student's t test). Statistical comparison was performed on data collected after the third stimulation. Data are representative of the results of three independent experiments.
Ras
V12 transformation (31) . Moreover, Ras V12 transformation demonstrates a strict dependence upon the interaction of KSR1 with ERK (30, 31) . With MEFs expressing KSR2, however, the coordination between ERK activation, proliferation, and transformation is disrupted. Although growth factor-induced ERK activity was suppressed by the high levels of KSR2 expression, these cells grew at higher rates than control MEFs and MEFs expressing low levels of KSR2. KSR2.C907Y, which disrupts the interaction of KSR2 with MEK, mediates growth factor-induced ERK activation but does not enhance cell proliferation. Moreover, only the high levels of KSR2 expression, which reduce ERK activation, contribute to Ras V12 -induced transformation. The conclusion that KSR2- hairpin, the KSR2-specific short hairpin, the KSR2-specific short hairpin and the constitutively active AMPK␣2 (AMPK␣-CA), or the nontargeting short hairpin and dominant-negative AMPK␣2 (AMPK␣-KD) were seeded in poly(HEMA)-coated plates, and the ability to grow in an anchorage-independent manner was examined by assessing cell viability using CellTiter-Glo at the indicated time points. Data representative of at least three independent experiments are illustrated as means Ϯ standard errors of the means of the results determined for triplicate samples. Additionally, anchorage-independent growth of MIN6 (C) and NG108-15 (D) cells was examined after plating in soft agar. Data are illustrated as the number of colonies per 5 ϫ 10 3 cells present after 4 weeks (C) and 2 weeks (D). The lower panel shows representative photomicrographs of colonies for each sample. Data are representative of at least three independent experiments and illustrated as means Ϯ standard deviations of the results determined with triplicate samples. Immunoblots (IB) demonstrating the expression of the myc-tagged AMPK␣ constructs in MIN6 (E) and NG108-15 (F) cells are shown. *, P Յ 0.01; **, P Յ 0.001 (two-tailed Student's t test). dependent ERK activation is dispensable for KSR2-dependent cell proliferation and transformation is bolstered by the demonstration that disrupting the interaction of KSR2 with ERK did not alter the biological action of KSR2. Furthermore, KSR2 or KSR1 knockdown in MIN6 and NG108-15 cells reduced cell proliferation, but only KSR1 knockdown affected growth factor-mediated ERK activation. These data show that KSR2 mediates its effect on cell proliferation differently from KSR1 (30, 31, 44) despite their strong homology and ability to activate the same kinase cascade. Examination of ksr genes in C. elegans revealed that ksr1 and ksr2 have unique and redundant functions in mediating Ras-dependent development (46) . Despite its exclusive contribution to germ line meiotic progression in nematodes, ksr2 function was presumed to be the result of its control over ERK phosphorylation in oocytes because ksr2 disruption caused acute disruption of mpk-1 activation. Manipulation of mammalian cells shows that KSR2 may contribute to Ras signaling via previously unrecognized ERKindependent effects on metabolism.
A role of KSR2 in normal metabolism in KSR2 Ϫ/Ϫ mice was recently identified (6) . KSR2 disruption in mice impaired AMPK activation, AMPK-regulated fatty acid oxidation, and thermogenesis, promoting obesity. AMPK activation was also affected by KSR2 knockdown in MIN6 (Fig. 5A ) and NG108-15 tumor cell lines (6) . These observations run counter to the concept that AMPK promotes catabolism at the expense of anabolic events common to continuously dividing tumor cells (16) . AMPK is a regulator of glycolysis and OXPHOS in nontumor tissues, promoting glycolysis via phosphorylation of PFK-2 and mitochondrial metabolism by mediating the activation of PGC-1␣ (36, 37, 53) . AMPK mediates the production of NADPH (22), a biosynthetic intermediate required for the reduction of reactive oxygen species and synthesis of nucleic acids and lipids (8, 26) . The current data suggest a prominent role for AMPK in marshalling the nutrients and biosynthetic intermediates necessary for sustained macromolecular biosynthesis and ATP generation required in continuously proliferating tumor cells. Therefore, it is conceivable that the depletion of KSR2 in tumor cells affects these AMPKmediated processes. Further studies should determine the role of KSR2 in the production of these biosynthetic intermediates and its dependence on AMPK.
KSR2 regulation of tumor cell metabolism is not dependent on the Ras oncogene. The MIN6 cell line was established using SV40 small T antigen, and the NG108-15 cell line was created by a fusion of the N18TG-2 neuroblastoma and C6 BU-1 glioma (25, 40) . Ras mutations have not been detected in these cell lines, and yet KSR2 is required for their anchorage-independent growth and metabolic capacity. KSR1 also retains the capacity for ERK-independent increases in glycolytic and OXPHOS capacity through ERKindependent induction of PGC-1␣ and ERR␣. Expression of PGC-1␣ and ERR␣ is essential to H-Ras V12 -dependent anchorage-independent growth (12) . The extent to which KSR1 depends on AMPK for the expression of PGC-1␣ and ERR␣ is not yet known. However, while proteomic analysis identified the interaction of KSR2 with all three subunits of the AMPK complex, endogenous AMPK was not detected in KSR1 immunoprecipitates (6, 10) . Thus, the mechanisms through which these scaffolds affect tumor cell metabolism may differ.
The depletion of KSR2 affected the rates of glycolysis, fatty acid oxidation, and glutaminolysis, all of which were restored with the expression of AMPK-CA. The reduced glycolytic and OXPHOS capacity and the lower rates of nutrient metabolism reduced cell proliferation in MIN6 and NG108-15 cells. Thus, while KSR2 is a scaffold for the Raf/MEK/ERK signaling pathway (10), KSR2 can promote cell proliferation and the transformed phenotype by regulating AMPK activity and cellular metabolism. These data suggest that KSR2 is behaving as a signaling node that can respond to mitogenic signaling while ensuring the availability of a proper energy supply. The identification of KSR1 and KSR2 as regulators of cell metabolism may provide an opportunity to target both mitogenic and metabolic signaling pathways essential to tumor growth and survival. 
